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Supplementary Appendix 
 
This appendix has been provided by the authors to give readers additional information 
about their work. 
 
Supplement to: Moran A, Zhao D, Gu D, et al. The Future Impact of  Population Growth 
and Aging on Coronary Heart Disease in China: Projections from the Coronary Heart 
Disease Policy Model-China. 
 
 
 
 
 
A1.  Population Assumptions  
 
The US Census Bureau international database[1] was used as the source for 
estimates of the adult Chinese population age 35-84 years (Appendix Table 1 below)  
because 1) the population estimates by age/sex for adults aged 35-84 in 2000 were quite 
similar to the estimates from the Chinese Census of 2000,[2] and projections of future 35 
year olds (Table 2 below) were available from the US Census database and not the 
Chinese National Bureau of Statistics.   
 
 
 
Appendix Table 1.  Population of China aged 35-84 years in the year 2000, by age and 
sex, U.S. Census Bureau International Database (used in the CHD Policy Model-
China). 
Population by Age and Sex, 2000 
   Midyear population 
Age Both  sexes  Male Female
35-39 102,588,845  52,588,414 50,000,431
40-44 82,102,517  42,636,756 39,465,761
45-49 83,933,762  43,095,380 40,838,382
50-54 61,044,234  31,699,045 29,345,189
55-59 45,869,786  23,875,932 21,993,854
60-64 40,827,108  21,152,731 19,674,377
65-69 34,703,549  17,560,938 17,142,611
70-74 24,986,765  12,141,707 12,845,058
75-79 15,806,768  7,084,405 8,722,363
80-84 7,938,300  3,212,400 4,725,900
85-89 3,130,048  1,102,901 2,027,147
90-94 832,031  233,206 598,825  2
 
Appendix Table 2.  Projected population of China aged 35 years in the years 2001-
2029, by sex, U.S. Census Bureau International Database (used in the CHD Policy 
Model-China). 
YEAR Males  Females 
2001 12,702,898  12,055,011
2002 11,611,867  10,932,090
2003 12,521,827  11,735,205
2004 13,764,163  13,065,102
2005 13,149,400  12,564,667
2006 13,236,969  12,368,116
2007 12,317,627  11,634,396
2008 12,073,845  11,646,067
2009 11,503,094  11,132,997
2010 10,587,460  10,217,905
2011 10,003,553  9,626,462
2012 9,461,310  9,090,618
2013 9,201,776  8,851,939
2014 9,437,871  9,046,089
2015 9,416,390  8,979,101
2016 9,086,373  8,576,822
2017 12,043,428  11,430,496
2018 10,044,172  9,746,499
2019 9,830,067  9,448,556
2020 9,867,333  9,354,966
2021 10,989,583  10,448,874
2022 13,056,164  12,418,353
2023 12,360,313  11,697,069
2024 12,598,862  11,808,453
2025 13,412,158  12,202,202
2026 11,011,614  10,219,689
2027 10,443,485  9,641,889
2028 10,168,950  9,338,966
2029 10,181,505  9,300,104
 
A2.  Mortality rate assumptions for China in 2002. 
The CHD Policy Model-China defined CHD as myocardial infarction (ICD-9 410, 412 
or ICD-10 I21, I22),  angina and other CHD (ICD-9 411, 413 and 414, or IC-10 I20, I23-I25), 
and a fixed proportion of “ill-defined” cardiovascular disease coded events and deaths (ICD-
9 codes 427.1, 427.4, 427.5, 428, 429.0, 429.1, 429.2, 429.9, 440.9 or ICD-10 I47.2, I49.0, 
I46, I50, I51.4, I51.5, I51.9, and I70.9).  The proportion of ill-defined cardiovascular disease 
coded deaths apportioned to CHD under liberal, “high ill-defined cardioscular disease   3
coding” and conservative, “low ill-defined coding” assumptions are listed below, according 
to the method developed by Lozano et al.[3]  The more conservative definition was used re-
apportion ill-defined coded cardiovascular disease deaths to CHD deaths in the main 
model. 
 
Appendix Table 3.  Proportion of deaths coded with ICD-9 codes 427.1, 427.4, 427.5, 
428, 429.0, 429.1, 429.2, 429.9, 440.9 re-allocated toward CHD deaths (based on 
Lozano et al.)[3] 
 
 
Target total mortality for the Chinese adults aged 35-84 years in the year 2002 were 
taken from the World Health Organization (WHO) estimates: 3.9 million total deaths for men 
and 3.3 million for women.  Age and sex-specific CHD and non-CHD mortality rates were 
estimated from the Chinese National Hypertension Epidemiology Follow-up Survey 
(CHEFS)[4] and then inflated by 30% to fit the ‘envelope’ of the WHO absolute mortality 
estimates. 
 
Appendix Table 4.  Original CHD deaths rates based on CHEFS estimates and 
inflated CHD death rates used in the CHD Policy Model-China.  Rates are 
deaths/100,000 person-years. 
 
Males 
Conservative 
(‘low ill-defined 
coding); main 
assumption 
Liberal  
(‘high ill-defined 
coding) 
Females 
Conservative 
(‘low ill-defined 
coding); main 
assumption 
Liberal  
(‘high ill-defined 
coding) 
35-44  0.107  0.107 35-44  0  0 
45-54  0.0395  0.4845 45-54  0.0505  0.2435 
55-64  0.1545  0.8475 55-64  0.129  0.6745 
65-74  0.2585  0.7795 65-74  0.2265  0.5420 
75-84  0.1315  0.409 75-84  0.115  0.2780 
Males 
Original 
CHEFS CHD 
death rates 
Inflated CHD 
death rates 
Females 
Original 
CHEFS CHD 
death rates 
Inflated CHD 
death rates 
35-44  9.2  12 35-44  3.8  5 
45-54  19.8  26 45-54  13.0  17 
55-64  108.1  141 55-64  57.3  74 
65-74  275.1  358 65-74  181.3  236 
75-84  522.3  679 75-84  345.3  449   4
A3.  Incidence of CHD in persons with no prior diagnosis of CHD. 
 
CHD incidence in men and women aged 35-84 years with no prior CHD diagnosis 
was based on 10-year incidence rates from the Chinese Multi-provincial Cohort Study 
(CMCS),[5] and calibrated to fit with CHD mortality and case-fatality assumptions. 
 
Appendix Table 5.  Calibrated incidence of CHD in persons free of CHD, the CHD 
Policy Model-China.  Rates are cases of CHD/100,000 person-years. 
 
 
A4. Prevalence of angina and total CHD 
The Rose questionnaire has never been validated in a Chinese population.  Results 
from one study performed in United Kingdom South Asians and Europeans suggest that the 
Rose questionnaire, or at least a diagnosis of ‘definite angina’ defined by the questionnaire 
may not be reproducible across populations.[6]  We suspect that Rose questionnaire self-
reported angina from the InterASIA study[7] likely included many false positives, a 
conclusion reached by others regarding Rose-diagnosed angina in their studies.[8, 9]  For 
the CHD Policy Model-China, prevalence was calibrated to match incidence, case-fatality, 
and mortality assumptions.  In particular, the prevalence of angina was driven 
predominantly by the incidence of angina (ICD-9 413) observed in the Chinese Multi-
provincial Cohort Study (CMCS, see table below). In the CMCS, incident angina was 
defined based on cases of angina presenting for medical attention.  The unreliable estimate 
for incidence in females 65-74 years old was fitted to known age trends from the 
Framingham Study.[10] 
Males 
Policy Model-China CHD 
incidence  Females 
Policy Model-China CHD 
incidence 
35-44 50  35-44  20 
45-54 75  45-54  40 
55-64 350  55-64  170 
65-74 670  65-74  420 
75-84 700  75-84  550   5
Appendix Table 6.  Angina Incidence in the CMCS, China, 1990-2001. 
Sex/Age Group  CMCS incidence of angina pectoris (ICD-9 413) in 
events/100,000 person-years 
 
M 35-44 
 
28.0 
M 45-54  16.8 
M 55-64  48.7 
M 65-74  85.0 
M 75-84  Not available 
 
  
F 35-44  14.2 
F 45-54  32.5 
F 55-64  65.2 
F 65-74  24.7 * 
F 75-84  Not available 
 
*Unreliable, based on few events 
 
Given the overall lower CHD incidence in China, the Policy Model-China’s  age-
specific prevalence of total CHD assumed for our model for 2000 correlates well with the % 
prevalence of angina pectoris assumed for the CHD Policy Model-U.S. for the U.S. in 2000 
and that assumed for the 1996 U.S. Burden of Disease Study (see table below).  The China 
Model also assumes that prevalence of angina correlates with overall CHD incidence, so 
that the prevalence of angina is lower in Chinese women than Chinese men.  This is also 
the pattern assumed by the US Model and the US Burden of Disease Study. 
Appendix Table 7.  Comparison of angina prevalence assumed for the CHD Policy Model-
China with Rose questionnaire-diagnosed angina (InterASIA Study 2000-2001) and angina 
prevalence assumed for the United States for  the CHD Policy Model-USA and the U.S. Global 
Burden Study. 
Sex/Age 
Group 
InterASIA 
prevalence of 
angina (using the 
Rose 
questionnaire) 
CHDPM-China 
2000  
angina  prevalence 
assumption (fitted to 
incident angina in CMCS) 
CHDPM-USA 
2000  
angina  
prevalence 
GBD USA 1996 angina 
prevalence  
(approximations from 
Figure 4, Mathers et al.)[9] 
M 35-44  2.4  0.03  1.06  0.1 
M 45-54  2.7  0.54  3.24  1.2 
M 55-64  4.5  0.85  5.87  3.2 
M 65-74  3.0  2.67  8.71  5.0 
M 75-84  Not available  4.38  11.26  7.0 
F 35-44  4.2  0.03  0.74  0.2 
F 45-54  6.0  0.43  1.73  0.3 
F 55-64  4.5  0.51  3.44  1.0 
F 65-74  5.7  1.51  6.20  3.5 
F 75-84  Not available  3.10  9.26  6.2 
   6
A5. Case-fatality rate assumptions 
 
 Main CHD Policy Model-China 28-day case-fatality assumptions were estimated 
from pooled Beijing Sino-MONICA Study data from 1993-2004 (personal communication, 
Dong Zhao, MD, PhD, 2006) and the main age-specific CHD case-fatality rate assumptions 
were estimated from the overall rates.   Twenty-eight day case-fatality rates for ages 25-74 
years in the Beijing Sino-MONICA population were 53% for Chinese men and 66% for 
Chinese women.  Age specific total CHD (including incident myocardial infarction (MI), 
cardiac arrest, and angina) and ‘hard’ CHD (MI and cardiac arrest only) 28-day case fatality 
rates assumed for the CHD Policy Model-China are listed below. 
 
 
Appendix Table 8.  Age-specific 28-day CHD mortality rates assumed for the CHD Policy 
Model-China 
*Total CHD includes angina, MI, and arrest.  Hard CHD includes MI and arrest only. 
 
 
Case-fatality rates increased by 1% annually in Chinese men and women in the 
MONICA Beijing population during 1984-1993,[11] but have been declining since (personal 
communication, Dr.  Dong Zhao, 2006, see figure below).  In light of these dynamic 
changes, we took the conservative approach of assuming no change in age-specific CHD 
case-fatality, but did model the consequences of assuming higher (similar to the 1984-1993 
Beijing rates) and lower (similar to Beijing rates 1999-2004) case-fatality rates. 
Males 
Policy Model-China 
28-day total CHD 
Case-fatality* 
Policy Model-China 
28-day hard CHD 
Case-fatality  Females
Policy Model-
China 28-day total 
CHD Case-fatality 
Policy Model-
China 28-day hard 
CHD Case-fatality 
 
35-44 
 
0.18 
 
0.38 
 
35-44 
 
0.28 
 
0.61 
45-54 0.28  0.46  45-54  0.32 0.53 
55-64 0.37  0.48  55-64  0.42 0.60 
65-74 0.46  0.55  65-74  0.54 0.63 
75-84 0.60  0.67 
 
75-84  0.73 0.76   7
 
Appendix Figure 1. CHD Case-fatality, Beijing-MONICA 1984-2004 (unpublished data) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A6. Transition rates between risk factors 
 
 
Transfers from one risk factor level to another were included to preserve the 
InterASIA Study proportions of the population with each risk factor level. For example, the 
proportion of 35-44 year old men with low (<100 mg/dL) LDL cholesterol is 0.482. For 45-54 
year old men the proportion is 0.437. The shift toward higher LDL cholesterol levels is most 
likely caused by increasing LDL levels as people age. In higher age ranges, this trend 
reverses, so that by age 75-84, the proportion is 0.403. The change in the upper age 
ranges is most likely due to a more complex array of factors, including the fact that people 
with higher risk are more likely to die. Annual transfer rates between risk factor levels were 
calculated to reduce the low risk population from 0.482 to 0.437 over 10 years, without 
regard to the reason for the change, but taking into account the effect of the Model’s CHD 
incidence and non-CHD death rates. 
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A7.  Durations of non-fatal CHD sequelae: angina and congestive heart failure 
 
For incident cases of angina and congestive heart failure, we assumed the age-
specific mean durations assumed in 2004 by the WHO for the WPRO region, 90% of which 
comprises China (table below, personal communication, Colin Mathers, PhD, August, 
2008).   
 
Appendix Table 9.  Durations of sequelae: angina pectoris (AP) and congestive heart 
failure (CHF) assumed for the WPR B1 region, the Global Burden of Disease Study, 
2004. 
WPR B1 2004     AP  CHF 
age  sex  Duration (years)  Duration (years) 
0 male  42.3827 0
5  male  33.2462 0
15  male  25.8521 0
30  male  16.375 6.3764
45  male  10.9901 4.0572
60  male  7.9362 2.5867
70  male  5.2153 1.9021
80  male  2.7979 1.4708
0 female  48.0652 0
5  female  38.8578 0
15  female  30.4496 0
30  female  20.2403 10.4458
45  female  13.1913 7.0091
60  female  8.6265 4.2932
70  female  5.3842 2.7068
80  female  2.8748 1.9002
 
 
We do not assume remission from the anginal state in our China model both 
because rates of revascularization in the stable angina population in China are not well 
known, and because clinical trials suggest that patients with angina continue to have 
symptoms after medical or procedural intervention.[12]   We specifically state that we 
assume no remission from angina or heart failure. 
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